ESR1 and breast carcinoma: Estrogen receptor alpha (ERα), the hormone (β‐estradiol)‐sensing nuclear receptor frequently overexpressed in breast cancer, is heavily post‐translationally modified, including 26 phosphorylated residues (Hornbeck et al, 2012).